Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 545,448 | 580,752 | 537,656 | 506,121 | 491,976 |
| Cost of Goods | 239,805 | 248,313 | 234,557 | 233,647 | 217,974 |
| Gross Profit | 305,643 | 332,439 | 303,099 | 272,474 | 274,002 |
| Operating Expenses | 189,098 | 187,158 | 190,612 | 175,313 | 174,563 |
| Operating Income | 117,350 | 145,594 | 113,044 | 97,808 | 100,413 |
| Interest Expense | 8,453 | 8,457 | 9,274 | 9,717 | 9,764 |
| Other Income | 142 | 172 | 579 | 1,595 | 1,400 |
| Pre-tax Income | 109,039 | 137,309 | 104,349 | 89,686 | 92,049 |
| Income Tax | 15,825 | 28,629 | 14,873 | 51,396 | 21,535 |
| Net Income Continuous | 93,214 | 108,680 | 89,476 | 38,290 | 70,514 |
| Minority Interests | -37 | -11 | 25 | 33 | 3 |
| Net Income | $93,251 | $108,691 | $89,451 | $38,257 | $70,511 |
| EPS Basic Total Ops | 1.07 | 1.25 | 1.02 | 0.44 | 0.81 |
| EPS Basic Continuous Ops | 1.07 | 1.25 | 1.02 | 0.44 | 0.81 |
| EPS Diluted Total Ops | 1.05 | 1.23 | 1.01 | 0.43 | 0.79 |
| EPS Diluted Continuous Ops | 1.05 | 1.23 | 1.01 | 0.43 | 0.79 |
| EBITDA(a) | $138,228 | $166,486 | $133,848 | $119,328 | $121,140 |